U.S. Representative Angie Craig (D-Minnesota) introduced a bill last week that aims to create a government-run public health insurance option on the Affordable Care Act Marketplaces. The bill is called

It sounds like something out of a dystopian novel, but it’s true. People can now place bets on clinical trial outcomes and FDA regulatory decisions like they would bet on

Each year when spring and summer arrive, primary care offices are filled with patients experiencing a variety of vague symptoms: itchy eyes, runny noses, exhaustion, and fogginess. While navigating this

AI is increasingly being used in clinical settings and has the potential to improve patient outcomes, but today’s payment models are limiting its adoption, according to a report released last

AI is playing an increasingly central role in patient care at hospitals across the country, but the same models driving that innovation are also being turned against providers by hackers.

Medical device companies and digital health founders that are developing and deploying healthcare artificial intelligence (AI) tools face a recurring product-design conflict. The strongest business case is usually an improving

The women’s oncology market is poised for significant growth, but persistent gaps in funding, innovation and patient access continue to hold back progress, according to a new PwC report. The

Statins are a standard drug for managing high cholesterol, but for patients who need something stronger, a newer class of medicines has become another option. In the more than a

Life sciences companies and investors continue to navigate a complex and challenging investment landscape – marked by high interest rates, a volatile regulatory environment, tight venture capital (VC) markets, and

Eli Lilly’s scope in neuroscience is broadening to psychedelics through a deal to buy AtaiBeckley, a clinical-stage company whose lead program might offer advantages over a blockbuster Johnson & Johnson